This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

How Tesla Stretches Earnings Quality

08/19/14 - 09:12 AM EDT

At some point it won't be just the cars that matter.


Greenberg: Getting Restaurant IPO Indignation

08/14/14 - 02:37 PM EDT

Noodles & Co., Potbelly and Papa Murphy's were all well-established before going public and so far, all three are causing investors to grab the Tums.


Greenberg: Why Michael Kors Should Stop Giving Guidance

08/05/14 - 07:23 AM EDT

If Michael Kors is focused on the longterm, not on quarter-to-quarter returns for investors, then it needs to stop giving quarterly guidance.


Greenberg: Best Part About the Twitter Quarter

07/30/14 - 09:41 AM EDT

Twitter showed its willing to talk about its non-active users, the lurkers rather than the tweeters, and how to get everyone involved.


Greenberg: Is Today's Market Really Different from 1999?

07/29/14 - 04:29 PM EDT

A lot of things are the same, but don't try to predict when the bubble might burst


Greenberg: An Inflection Point for Herbalife?

07/29/14 - 08:06 AM EDT

Herbalife surprised investors not with lower-than-expected profit but with revenue, an ominous sign of a slowing growing.


Greenberg: Ackman and Herbalife -- The Day After

07/23/14 - 09:45 AM EDT

Bill Ackman's presentation failed to impress investors, but it probably should have, as Ackman raised several important points.


Greenberg: Ackman's 'Anticappointment'

07/22/14 - 06:53 PM EDT

If the 25% rise in Herbalife's stock proves nothing else, it's that the market hates 'anticappointment,' as one friend puts it, referring to Ackman's highly promoted multi-hour presentation.


Greenberg: Allergan's Dilemma

07/21/14 - 04:21 PM EDT

Allergan is in a tight spot: It had better hope, if it's successful fighting off Valeant, that its stock price doesn't tumble -- and in a year has rebounded!


Greenberg: Kors Calls Speculation 'False and Unfounded'

07/21/14 - 08:30 AM EDT

Michael Kors challenged Herb Greenberg's observation regarding the company's upcoming earnings report and analysts' recent negative action.


Herb Greenberg is the editor of Herb Greenberg's Reality Check, a subscription newsletter designed to help investors better manage risk.

Greenberg has been a financial journalist for more than 30 years, working most recently as a senior stocks commentator on CNBC's business day programming and on He was also co-president of Greenberg Meritz Research & Analytics. He is a former weekend investor columnist for The Wall Street Journal and a former senior columnist for MarketWatch.

Expand Bio +

Prior to joining MarketWatch, Greenberg was senior columnist forTheStreet. He previously spent 10 years as the "Business Insider" columnist for the San Francisco Chronicle and nearly seven years asFortune magazine's monthly "Against the Grain" columnist. Before that, he was the New York financial correspondent for the Chicago Tribune and a financial reporter in its Chicago newsroom. Greenberg has held various positions at other media outlets including Crain's Chicago Business and the St. Paul Pioneer Press.

Close Bio -


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Herb's Tweets

Brokerage Partners

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs